- Original Research
- Open access
- Published:
Perioperative use of antibiotics in full-thickness rectal biopsies for Hirschsprung’s disease
Annals of Pediatric Surgery volume 18, Article number: 48 (2022)
Abstract
Background
There is no consensus on the use of perioperative antibiotic in full-thickness rectal biopsies (FTB) in children suspected for Hirschsprung disease. The primary objective of this study was to examine the effect of perioperative antibiotics on infectious and overall complications rate in FTB performed in children under the age of 1 year.
Methods
A retrospective chart review. Two time periods were compared—one with and one without the routine use of perioperative antibiotics. The treatment included cefuroxime 100 mg/kg and metronidazole 20 mg/kg administered intravenously at anesthesia induction followed by peroral administration of amoxicillin 50 mg/kg with Clavulanic acid 12.5 mg/kg three times a day t.i.d. for 3 days postoperative.
Results
In the group with perioperative antibiotics the infectious complications rate was 3.3% compared to 13.4% in the group without (p = 0.03) with fever as the most common. The overall complication rate was 11.3% and 15.2%, respectively (p = 0.43).
Conclusion
Perioperative antibiotics significantly reduced the rate of infectious complications, but not the rate of overall complication rate after a full thickness rectal biopsy in children under the age of 1 year.
Background
The definitive diagnosis of Hirschsprung disease (HD) relies on the histological demonstration of the absence of ganglion cells in myenteric (Auerbach) and submucosal (Meissner) plexus from transanal rectal biopsies. The biopsies may be performed as full thickness biopsies (FTB) or as suction biopsies. By FTB the mucosa, submucosa and the muscular layers should be included with preservation of the outermost muscular fibers and the serosal layer, but this always carry the risk of perforation into the perirectal fatty tissue. An overall complication rate varying from 0 to 8.9% has been reported for FTB in larger studies [1,2,3,4].
The use of perioperative antibiotics has become a gold standard in gastrointestinal surgery [5]. The ERNICA guidelines on Hirschsprung´s disease do not include any recommendations on perioperative antibiotics at rectal biopsy [6]. There are no studies on the effect in FTB but it has been recommended in patients with congenital heart disease [2].
A newly published study has shown that the use of antibiotics within the first year of life increases the risk of bacteria carrying genes of resistance in the infant gut [7]. Therefore, the use of perioperative antibiotic must be weighed against the severity of complications, the number of patients needed to treat to avoid a complication and the risk of developing bacterial resistance [8].
The primary objective of this study was to examine the effect of perioperative antibiotics on infectious and overall complications rate in FTB in children under the age of 1 year.
Material and methods
We performed a retrospective chart review of children below the age of 1 year who underwent FTB at Odense University Hospital (OUH), Denmark, which is a tertiary referral center for pediatric surgery in Western Denmark. Patients did not undergo any other diagnostic workup and no bowl preparation was performed prior to the FTB.
Routine administration of perioperative antibiotics was introduced in late 2015 for patients under the age of 1 year. Therefore, we included patients from two different time periods. One period without antibiotics from 1 January 2010 to 31 December 2014 and one with antibiotics from 1 July 2016 to 31 December 2019. There were no other differences in treatment or care between the two time periods.
At discharge, parents were informed to contact the department in case of fever defined as a temperature > 38.5 °C, visible rectal bleeding or pain that did not respond to paracetamol 12.5 mg/kg, t.i.d. The attending pediatricians at our institution is the primary responsible for the post-operative care after FTB and for contacts with parents after discharge.
Postoperative complication was defined as any contact to the department in relation to the biopsy either by phone or admittance within 30 days postoperative.
The following outcomes were registered: fever, bleeding, pain, vomiting, and readmission. In case of additional antibiotic treatment, the type and route of administration was registered.
Information on blood tests (white blood cell count, CRP concentration) and result of blood culture were retrieved for children readmitted with fever.
All complications were classified according to the Clavien-Dindo Classification (CD) [9] and the Comprehensive Complication Index (CCI) [10] was calculated for each child.
Surgical procedure
For the surgical procedure, a suture was placed in the posterior wall of rectum, approximately 2 cm above the dentate line. The rectal wall was raised by traction and a 3–5 mm FTB was cut out with scissors. Hemostasis was secured by bipolar electrocoagulation and the defect was sutured.
The antibiotic regime consisted of intravenous administration of cefuroxime 100 mg/kg and metronidazole 20 mg/kg administered perioperative followed by oral administration of a mixture of amoxicillin 50 mg/kg and clavulanic acid 12.5 mg/kg, t.i.d. for 3 days.
Inclusion and exclusion criteria
A search was conducted in the local pathology database to identify patients eligible for inclusion: “T68*” (“rectal mucosa”) and “TX9600” (“rectum”), combined with M21000 (“aganglionosis”) or M01000 (“normal tissue”) or M09011/M09010 (“material not suitable for a conclusive diagnosis.”
Exclusion criteria were children older than 1 year of age at the time of biopsy, biopsy taken as part of another surgical intervention, administration of antibiotics within 2 days prior to the day of biopsy and any deviation from the standard perioperative antibiotic treatment during the intervention period.
Statistical analysis
Study data were managed using REDCap (Research Electronic Data Capture) [11] hosted by OPEN (Open Patient data Explorative Network)
Continuous data are presented as mean and standard deviation or medians and ranges. Categorical data are presented as counts and proportions. Student’s test was to compare the differences in temperature. Mann-Whitney U test were used to compare the differences in CRP, white blood cell count and CCI. Fisher’s exact test was used to compare the differences in the frequencies of complications. Pearsons’s chi-squared test was used when calculating differences in sex and age. Statistical calculations were performed using Stata software (StataCorp., 2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp. LLC). P values below 0.05 were considered statistically significant.
Results
A total of 112 patients fulfilled the inclusion criteria in the first period without perioperative antibiotics and 115 patients in the second period with perioperative antibiotics.
Complications were registered in 13 children (11.3%) with perioperative antibiotics and 17 children (15.2%) in the period without (p = 0.43) (Table 1). The CCI was 1.31 ± 4.40 in the group with perioperative antibiotics and 2.75 ± 7.44 in the group without, p = 0.09.
Fever was the most common complication and registered in 5 children (3.3%) with perioperative antibiotics and in 15 children (13.4%) without (p = 0.03). The majority (90%) of patients who developed fever after FTB across the two groups presented themselves within 48 h.
Patients who did not receive perioperative antibiotic had a significant higher rate of postoperative fever rated as a ≥CD-II which was treated with intravenous antibiotics (9% vs 1%, p = 0.006).
The absolute risk reduction (ARR) of fever with antibiotics was 10.1% and the number needed to treat (NNT) was 10 (Table 2).
Among patients readmitted with fever there were no significant differences in temperature, white blood cell count or CRP concentration at first assessment, between the two groups (Table 3). All blood cultures in both groups were negative.
Discussion
This study found that the use of perioperative antibiotics significantly reduced the rate of infectious complications, but not the rate of overall complications.
The frequency of complications with a ≥ CD-II was significantly higher in the group without perioperative antibiotic. When complications were weighted based on their severity and reported as CCI, no significant differences were found. CCI has shown to be more sensitive to describe the severity of complications compared to CD alone [12, 13].
Severe complications after rectal biopsies are rare. In this study the overall complication rate for CD-IIIb was 2%. Treatment included drainage of a rectal abscess, electrocoagulation of biopsy site, and treatment of an anal fistula with a Seton suture. All patients recovered with no sequelae.
Of those readmitted with fever, there were no significant differences in temperature, white blood cell count, and CRP concentration between the two groups. All blood cultures performed in both groups were negative. This indicates that early postoperative fever is most likely a response to surgery and not an infectious complication [14].
Due to the relatively small number of patients included we did not perform an analysis of the risk factors for complications in relation to the different pathology coding.
There are several limitations to this study, including those inherent to any single-center retrospective chart study, e.g., missing variables, difficulty in establishing cause and effect and variance in the quality of information recorded by medical professionals. Nonetheless, this study is to our knowledge the first to examine the overall rate of complications to FTB with and without perioperative antibiotics.
We are fully aware that the gold standard for perioperative antibiotic in gastrointestinal surgery is a single dose covering both anaerobe and gram-negative bacteria administered within 1 h prior to surgery. Perioperative antibiotics should generally be discontinued within 24 h if there is no sign of infections [15, 16]. The regimen used in the present study with an extended postoperative regime for 3 days was chosen to obtain maximal effect. Whether the postoperative administration had an additive effect is unknown.
These findings may indicate that perioperative antibiotics is not needed when performing full thickness rectal biopsies in children under 1 year of age. To answer this question, the research group have a large-scaled randomized controlled study in the pipeline which hopefully will include multiple centers.
Conclusion
Perioperative antibiotics significantly reduced the rate of infectious complications, but not the rate of overall complication rate after a full thickness rectal biopsy in children under the age of 1 year.
Availability of data and materials
Data will be uploaded as an appendix
Abbreviations
- CCI:
-
Comprehensive Complication Index
- CD:
-
Clavien-Dindo Classification
- FTB:
-
Full-thickness biopsies
- HD:
-
Hirschsprung disease
- OPEN:
-
Open Patient data Explorative Network
- OUH:
-
Odense University Hospital
- REDCap:
-
Research Electronic Data Capture
References
Muise ED, Hardee S, Morotti RA, Cowles RA, et al. J Surg Res. 2016;201(1):149–55.
Alizai NK, Batcup G, Dixon MF, Stringer MD. Rectal biopsy for Hirschsprung's disease: what is the optimum method? Pediatr Surg Int. 1998;13(2-3):121–4.
Bamigbola KTN, Abdulrasheed A, Abdur-Rahman LO, Oyinloye AO, Abdulraheem NT, Adeniran JO. Experience with full-thickness rectal biopsy in the evaluation of patients with suspected Hirschsprung’s disease. Ann Pediatr Surg. 2014;10(2):42–5.
Bjorn N, Rasmussen L, Qvist N, Detlefsen S, Ellebaek MB. Full-thickness rectal biopsy in children suspicious for Hirschsprung's disease is safe and yields a low number of insufficient biopsies. J Pediatr Surg. 2018;53(10):1942–4.
Nelson RL, Gladman E, Barbateskovic M. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev. 2014;2014(5):CD001181.
Kyrklund K, Sloots CEJ, de Blaauw I, et al. ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease. Orphanet J Rare Dis. 2020;15(1):164.
Li X, Stokholm J, Brejnrod A, et al. The infant gut resistome associates with E. coli, environmental exposures, gut microbiome maturity, and asthma-associated bacterial composition. Cell Host Microbe. 2021;29(6):975–987 e974.
Control ECfDPa. Survey of healthcare workers’ knowledge, attitudes and behaviours on antibiotics, antibiotic use and antibiotic resistance in the EU/EEA. In:2019.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.
Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien PA. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258(1):1–7.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
Slankamenac K, Nederlof N, Pessaux P, et al. The comprehensive complication index: a novel and more sensitive endpoint for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014;260(5):757–62 discussion 762-753.
de la Plaza LR, Ramia Angel JM, Bellon JM, et al. Clinical validation of the comprehensive complication index as a measure of postoperative morbidity at a surgical department: a prospective study. Ann Surg. 2018;268(5):838–44.
Corkum KS, Hunter CJ, Grabowski JE, Lautz TB. Early postoperative fever workup in children: utilization and utility. J Pediatr Surg. 2018;53(7):1295–300.
Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43(3):322–30.
Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett. 2009;7(82):47–52. PMID: 19461558.
Acknowledgements
Not applicable
Funding
This study was not funded
Author information
Authors and Affiliations
Contributions
N.S Schiellerup conceived and designed the study, collected and analyzed the data, and drafted the manuscript. S. Möller analyzed the data and approved the final version of the manuscript. A. Linneman and P. Ehlers provided critical revisions and approved the final version of the manuscript. N. Bjørn, N. Qvist, and M.B. Ellebæk conceived and designed the study, provided critical revisions, and approved the final version of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The introduction of the antibiotic regimen was based on an institutional decision without the necessity of any approvals from local ethical committee. All parents were informed preoperatively by the procedure, possible complications, and peri-and postoperative treatment. Local and regional authorities approved the journal access and data retrieval. Danish Patient Safety Authority Approval nr 3-3013-2822/1
Region of Southern Denmark approval, 19/3684.
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Schiellerup, N.S., Bjørn, N., Linneman, A. et al. Perioperative use of antibiotics in full-thickness rectal biopsies for Hirschsprung’s disease. Ann Pediatr Surg 18, 48 (2022). https://doi.org/10.1186/s43159-022-00182-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43159-022-00182-3